Burns John Thomas has filed 11 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 300000 shares of SELLAS Life Sciences Group, Inc. ($SLS) on January 07, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2026 | SELLAS Life Sciences Group, Inc. | $SLS | Burns John Thomas | CFO | A | Common Stock | 300000 | $0.00 | 554,327.0000 | 142,442,239 | 117.96% | 0.21% |
| Dec. 3, 2025 | SELLAS Life Sciences Group, Inc. | $SLS | Burns John Thomas | CFO | J | Common Stock | 58592 | $1.50 | 254,327.0000 | 142,442,239 | 18.72% | 0.04% |
| Jan. 10, 2025 | SELLAS Life Sciences Group, Inc. | $SLS | Burns John Thomas | CFO | A | Stock Option (Right to Buy) | 169500 | $0.00 | 169,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 10, 2025 | SELLAS Life Sciences Group, Inc. | $SLS | Burns John Thomas | CFO | A | Common Stock | 81300 | $0.00 | 299,062.0000 | 0 | 37.33% | 0.00% |
| Jan. 10, 2025 | SELLAS Life Sciences Group, Inc. | $SLS | Burns John Thomas | CFO | A | Common Stock | 113000 | $0.00 | 217,762.0000 | 0 | 107.86% | 0.00% |
| Dec. 4, 2024 | SELLAS Life Sciences Group, Inc. | $SLS | Burns John Thomas | CFO | J | Common Stock | 7165 | $1.13 | 104,762.0000 | 0 | 6.40% | 0.00% |
| Jan. 22, 2024 | SELLAS Life Sciences Group, Inc. | $SLS | Burns John Thomas | CFO | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2024 | SELLAS Life Sciences Group, Inc. | $SLS | Burns John Thomas | CFO | A | Common Stock | 47000 | $0.00 | 101,927.0000 | 0 | 85.57% | 0.00% |
| Dec. 6, 2023 | SELLAS Life Sciences Group, Inc. | $SLS | Burns John Thomas | CFO | J | Class A Common Stock | 2929 | $1.08 | 54,927.0000 | 0 | 5.06% | 0.00% |
| Feb. 2, 2023 | SELLAS Life Sciences Group, Inc. | $SLS | Burns John Thomas | CFO | A | Common Stock | 20000 | $0.00 | 49,347.0000 | 0 | 68.15% | 0.00% |
| Feb. 2, 2023 | SELLAS Life Sciences Group, Inc. | $SLS | Burns John Thomas | CFO | A | Stock Option Right to Buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |